News for BIOL Stock

BIOLASE Voluntarily Initiates Chapter 11 Proceedings BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen BIOLASE Announces Delisting from Nasdaq Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability BIOLASE to Report First Quarter 2024 Results on May 13, 2024 Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024 BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023 BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocol BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023 BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023 BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT BIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARD BIOLASE Announces Grand Opening of Training Facility to Reach Wider Universe of Dental Practitioners; First-Hand Experience Using Leading Dental Laser Technology Expected to Generate Increased Revenue Opportunities BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH - 22ND BIOLASE INTEGRATES DIODE LASER TECHNOLOGY WITH PET DENTAL SERVICES BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK BIOLASE Takes Steps to Improve Operating Efficiency as the Company Pursues Sales and Profitability Goals BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023 BIOLASE TO REPORT FIRST QUARTER 2023 RESULTS ON MAY 11, 2023 BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023 BIOLASE GATHERS KEY OPINION LEADERS AND DENTAL CLINICIANS TO HIGHLIGHT TONGUE-TIE TREATMENT BEST PRACTICES BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2022 RESULTS ON MARCH 28, 2023 BIOLASE PLANS TO LAUNCH SEASON 2 OF ITS POPULAR PODCAST SERIES BIOLASE LAUNCHES E-COMMERCE SITE TO ENHANCE POSITIVE USER EXPERIENCE AND STREAMLINE THE PURCHASING PROCESS TO CREATE GREATER EFFICIENCIES FOR DENTAL PRACTITIONERS BIOLASE ENTERS THE SKIN RESURFACING MARKET IN THE U.S. WITH THE LAUNCH OF A NEW WATERLASE FRACTIONAL HANDPIECE BIOLASE FURTHER ENHANCES MARKET AWARENESS CAMPAIGN WITH THE MUCH ANTICIPATED LAUNCH OF NEW EDUCATION PORTAL BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE BIOLASE RECEIVES SECOND TOP WORKPLACES 2022 AWARD Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS BIOLASE MAINTAINS POSITIVE MOMENTUM THROUGH YEAR END WITH SOLID FOURTH QUARTER REVENUE GROWTH; SIGNIFICANT MARKET OPPORTUNITY AND INDUSTRY-LEADING PRODUCT SUPPORT EXPECTATION FOR ROBUST REVENUE GROWTH IN 2023 BIOLASE RECEIVES TOP WORKPLACES 2022 AWARD BIOLASE INC. ANNOUNCES PRICING OF APPROXIMATELY $9.75 MILLION UNDERWRITTEN PUBLIC OFFERING BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE BIOLASE, Inc to Report Third Quarter 2022 Results on November 10, 2022 BIOLASE NAMES DR. RUSSELL MORROW AS CHIEF DENTAL OFFICER BIOLASE LAUNCHES RESEARCH GRANT PORTAL TO ACCELERATE CLINICAL STUDIES ON INNOVATIVE DENTAL LASER TECHNOLOGY BIOLASE DOCUSERIES, "TALK DENTAL TO ME" TO BE PRODUCED BY PROVIDENCE FILM GROUP BIOLASE ANNOUNCES DEVELOPMENT OF STRATEGIC PLAN TO PARTNER WITH POSTGRADUATE DENTAL SPECIALTY PROGRAMS ACROSS THE U.S. BIOLASE TO PARTICIPATE IN THE LAKE STREET 6TH ANNUAL BEST IDEAS GROWTH CONFERENCE SEPTEMBER 14, 2022 BIOLASE DELIVERS 34% REVENUE GROWTH YEAR OVER YEAR IN SECOND QUARTER BIOLASE, Inc to Report Second Quarter 2022 Results on August 11, 2022 BIOLASE EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW UNITED STATES AND FOREIGN PATENTS BIOLASE ANNOUNCES TRAINING INITIATIVE WITH EINSTEIN HEALTHCARE NETWORK'S GENERAL DENTISTRY RESIDENCY PROGRAM BIOLASE ANNOUNCES PROMOTIONS OF KEY TEAM MEMBERS BIOLASE ANNOUNCES SUPPORT FOR TEAMSMILE PROGRAM BIOLASE ENTERS INTO FAVORABLE CREDIT AGREEMENT AMENDMENT BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market BIOLASE ANNOUNCES SUPPORT FOR PROJECT HOME BIOLASE ANNOUNCES ADVANCING DENTISTRY WEBINARS FOR Q3 2022 BIOLASE ANNOUNCES ADVANCING DENTISTRY PODCAST BIOLASE ANNOUNCES INAUGURAL CLINICAL EXCELLENCE FORUM BIOLASE SIGNS LEASE TO EXPAND TRAINING AND EDUCATION INITIATIVES BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022 BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD BIOLASE TO PARTICIPATE IN THE SPRING INTO ACTION BEST IDEAS VIRTUAL INVESTOR CONFERENCE MAY 17-20, 2022 BIOLASE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT BIOLASE MAINTAINS GROWTH MOMENTUM AS FIRST QUARTER REVENUE INCREASED 25% YEAR OVER YEAR BIOLASE STRENGTHENS ITS BOARD OF DIRECTORS WITH ADDITION OF SEASONED HEALTHCARE EXECUTIVE BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022 BIOLASE ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2022 VIRTUAL GROWTH CONFERENCE HOSTED BY M-VEST ON MARCH 28TH - 30TH BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021 BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022 BIOLASE Announces Distribution of Series G Preferred Stock to Holders of Its Common Stock BIOLASE Announces Continuation of Exclusive Collaboration with BMW Performance Center West (BMW PCW) and Winner of BMW Sweepstakes BIOLASE Announces Continuation of Exclusive Collaboration with BMW Performance Center West (BMW PCW) and Winner of BMW Sweepstakes BIOLASE ANNOUNCES POSTIVE PRELIMINARY REVENUE RESULTS FOR 2021 FOURTH QUARTER; ENTERS 2022 WITH SIGNIFICANT MOMENTUM BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists BIOLASE TO PRESENT AT THE H.C. WAINWRIGHT BIOCONNECT VIRTUAL INVESTOR CONFERENCE Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021 BIOLASE Urges Stockholders to Vote Now "FOR" Reverse Stock Split BIOLASE Reports 46% Revenue Growth In 2021 Third Quarter; Demand For Dental Lasers From New Customers Remains High And Continues To Fuel Growth BIOLASE Announces the Launch of Epic Hygiene Academy BIOLASE, Inc to Report Third Quarter 2021 Results on November 10, 2021 BIOLASE Issues Letter To Stockholders BIOLASE To Host Q&A And Webcast For Investors Regarding Its Special Meeting Of Stockholders BIOLASE and Healthy Smiles for Kids of Orange County (Healthy Smiles) Invite California Dental Community to Awareness Reception on Sept. 24 BIOLASE Schedule Of Investor Conferences For September 2021 BIOLASE Announces Clinical Advisory Partnership with Leading Endodontist Dr. L. Stephen Buchanan BIOLASE Expands Core Capabilities As It Appoints Three New Board Members With Significant Dental Experience BIOLASE Reports Significantly Improved Revenue In Its Second Quarter As Continued High Demand For Dental Lasers From New Customers Fueled Growth BIOLASE, Inc. To Report Second Quarter 2021 Results On August 12, 2021 Recent Studies Demonstrate BIOLASE's Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis BIOLASE to Present at the Summer Solstice Best Ideas From the Buy Side Conference on June 2, 2021 BIOLASE Hosts Pediatric Dental Laser Training with Healthy Smiles for Kids of Orange County BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers BIOLASE, Inc to Report First Quarter 2021 Results on May 13, 2021 BIOLASE Announces the Launch of Waterlase Pediatric Dental Academy BIOLASE Urges Stockholders To Vote "FOR" ALL Proposals At Upcoming Annual Meeting BIOLASE and EdgeEndo Announce Plans to Develop New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists BIOLASE Announces Collaboration with Einstein Healthcare Network's Residency in Endodontics BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021 BIOLASE To Participate In Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference BIOLASE Announces the Launch of Waterlase Perio Academy BIOLASE To Participate In H.C. Wainwright Investor Conference John R. Beaver Promoted To President And Chief Executive Officer Of BIOLASE; Will Leverage Dental Knowledge And Management Expertise To Achieve Growth Objectives BIOLASE, Inc. Announces Closing Of $14.4 Million Bought Offering BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement And Cancels Special Meeting Of Stockholders BIOLASE Urges Stockholders To Vote Today "FOR" The Reverse Stock Split BIOLASE Announces Preliminary Fourth Quarter Revenue Results And Current Cash Position BIOLASE Announces Agreement With DSO Dental Care Alliance To Expand Laser Adoption In Dental Offices Across The United States BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference BIOLASE Announces Exclusive Collaboration with BMW Performance Center West BIOLASE To Present At The 13th Annual LD Micro Main Event Conference BIOLASE Announces the Launch of Waterlase Endo Academy BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020 BIOLASE Reports Strong Sequential Revenue Growth In Third Quarter 2020 BIOLASE, Inc. to Report Third Quarter 2020 Results on November 12, 2020 BIOLASE Announces Launch On M-Vest BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth BIOLASE To Host Expert Panel Webinar On The Advantages Of Using Laser Dentistry In The Current Healthcare Environment; Dental Practices Resuming Normal Operations As Procedure Volumes Reach 70% Of Pre-COVID Levels BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis BIOLASE To Present At H.C. Wainwright's 22nd Annual Global Investor Conference BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference BIOLASE to Present at the LD Micro 500 Virtual Conference BIOLASE Regains Nasdaq Compliance For Minimum Stockholder Equity BIOLASE Reports Second Quarter 2020 Financial Results BIOLASE, Inc. to Report Second Quarter 2020 Results on August 13, 2020 BIOLASE Announces Expiration Of Oversubscribed Rights Offering BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020 BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering